Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02932553
Study type Interventional
Source Asan Medical Center
Contact
Status Withdrawn
Phase Phase 4
Start date April 19, 2017
Completion date April 19, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02845531 - Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death Phase 4
Withdrawn NCT02790528 - Statin Therapy In Patients With Vasospastic Angina Phase 4
Active, not recruiting NCT01318629 - Angina in Non Coronary Artery Disease N/A
Recruiting NCT05618132 - ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs N/A
Recruiting NCT00620204 - Efficacy Study of Atorvastatin to Treat Variant Angina Phase 4
Active, not recruiting NCT03477890 - Coronary Microvascular Function and CT Coronary Angiography (CorCTCA) N/A